Navigation Links
Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study
Date:12/15/2009

WILMINGTON, Del., Dec. 15 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) today voted 12 yes, 4 no, and 1 abstention that AstraZeneca has established sufficient benefit to offset the observed risks to support the use of CRESTOR® (rosuvastatin calcium) in individuals meeting the following criteria:

  • Men greater than or equal to 50 years, women greater than or equal to 60 years;
  • Fasting LDL < 130 mg/dL; hsCRP greater than or equal to 2.0 mg/L; Triglycerides <500 mg/dL;
  • No prior history of cardiovascular or cerebrovascular events or coronary heart disease (CHD) risk equivalent as defined by NCEP ATP-III guidelines.

The review, based on results of the JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) study, is part of the FDA's evaluation of the supplemental New Drug Application (sNDA) filed by AstraZeneca in April 2009 to update the CRESTOR Prescribing Information with information about the impact of CRESTOR on reducing the risk of cardiovascular events.

"AstraZeneca welcomes the Advisory Committee's positive vote," said Howard Hutchinson, M.D., Chief Medical Officer, AstraZeneca. "Today's discussions will help guide our ongoing dialogue with the FDA regarding our request for an indication that supports the use of CRESTOR for the prevention of cardiovascular disease in patients with an increased risk of experiencing cardiovascular events."

The FDA Advisory Committee also discussed four non-voting items related to a range of other observations in JUPITER, including adverse events and whether the JUPITER trial identified an appropriate new target patient population.

The FDA frequently convenes advisory committee meetings to obt
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
2. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
3. FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmabs ARZERRA(TM) (ofatumumab)
4. Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
5. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
6. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
7. NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
8. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
9. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
10. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
11. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... , May 30, 2015  Eisai Inc. announced today the ... that eribulin met the study,s primary endpoint evaluating overall survival ... (ADI), two types of advanced soft tissue sarcoma. These data ... of the American Society of Clinical Oncology (ASCO) in ... conference on Saturday, May 30, and also in an oral ...
(Date:5/30/2015)... May 30, 2015 Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... utility of Caris Molecular Intelligence®, the company,s panomic ... tumors that share histological features. In separate presentations ... of Clinical Oncology (ASCO) in Chicago, ...
(Date:5/29/2015)... - Alliance Principle Ingredients/Neutrical Solutions Inc., in consultation with ... Health Ginger in Bentonite (NPN 80053535) due to ... The product currently contains levels of lead beyond ... for adult dosing. Ginger in Bentonite ... Alliance Principle Ingredients / Neutrical Solutions Inc. has ...
Breaking Medicine Technology:Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
(Date:5/30/2015)... PA (PRWEB) May 30, 2015 You've probably ... cause injury and hearing loss. However, have you found a ... wife from Olathe, Kan., have exactly what you need. , ... removing wax build-up; dirt and dead, dry skin from the ... standard cotton swabs or anything on the market today for ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Promising clinical ... Oncology (ASCO) Annual Meeting 2015 show activity of the ... one case specifically against brain metastases and in another ... cancer patients. , "I am thrilled to have been ... her early 40s. She didn't have any other great ...
(Date:5/30/2015)... Houston, Texas (PRWEB) May 30, 2015 ... week for 2015’s Aesthetic Meeting, sponsored by the American ... many industry vendors on hand was Zeltiq, the parent ... the aesthetic space, CoolSculpting. With blazing growth, the ... , Zeltiq is currently in the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 NovaSure® endometrial ... lighten or stop periods, without the side effects ... can reduce or stop menstrual bleeding and works by ... (the part that causes the bleeding), with a quick ... suffer from heavy menstrual bleeding. Many women begin ...
(Date:5/30/2015)... NC (PRWEB) May 30, 2015 The ... that crocidolite asbestos has a high potential to cause ... the full story now on the Surviving Mesothelioma ... Institute of Occupational Medicine in Lodz, Poland found that, ... asbestos workers between 1970 and 2012, all of them ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2
... A unique study conducted by researchers at University of California ... children in the U.S. reveals that it is much higher ... warned about the possibility of back pain as a result ... more than 7000 school-going children present in the emergency room ...
... There is another feather in the coffee cap proposed by ... which says that drinking a cup of coffee with 100 ... procedure for the study involved 15 healthy men aged 26 ... caffeine and then when they consumed a placebo. 100 mg ...
... at preventing amputations and other disease-related complications in diabetics ... State of Tamil Nadu, courtesy a hospital initiative//. ... Initiative in the Community (DAPIC)" programme at Maragal Kandigai ... as a boon. DAPIC seeks to prevent diabetic foot ...
... activity in children's with autism and found that ... The Researchers found //that the autism children's had less ... and imitating others action and expressing facial response. The ... Neuroscience. ,Autism is a developmental disorder that ...
... executed prisoners being sold to foreigners for human transplantation ... Chinese health officials, who have been passive// about the ... widespread prevalence of such an inhuman act. ... from total strangers (were paid for their donation) and ...
... outbreak was detected in Ukraine (Crimea peninsula) and hence domestic ... for the purpose//. Health workers and emergency workers are recruited ... ducks and geese) and destroy them thereby the outbreak can ... bird that was killed. ,Various other ...
Cached Medicine News:Health News:Widespread Commercialisation Of Human Organ Donation In China 2
... The DataMate Laser ... System consists of laser-printable ... closure wristband and laser ... paperwork. The wristbands clear, ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... PDCs computer-generated Thermal Printing Wristbands and ... direct thermal and thermal transfer printers. ... activate a heat-sensitive thermal coating under ... printers use heat to transfer highly ...
... Designed for use in ... Alzheimer units, where you may ... which is easy to apply ... The band's width is increased ...
Medicine Products: